• 1. Copper-catalyzed three-component synthesis of 5-acetamidoimidazoles from carbodiimides, acyl chlorides and isocyanides
  Giulia Sapuppo,Qian Wang,Dominique Swinnen,Jieping Zhu Org. Chem. Front. 2014 1 240
• 2. Role of C, S, Se and P donor ligands in copper(i) mediated C–N and C–Si bond formation reactions
  Katam Srinivas,Ganesan Prabusankar RSC Adv. 2018 8 32269
• 3. Bismuth(iii)dichalcogenones as highly active catalysts in multiple C–C bond formation reactions
  Katam Srinivas,Arruri Sathyanarayana,Chatla Naga Babu,Ganesan Prabusankar Dalton Trans. 2016 45 5196
• 4. Clinically used antifungal azoles as ligands for gold(iii) complexes: the influence of the Au(iii) ion on the antimicrobial activity of the complex
  Nevena Lj. Stevanovi?,Jakob Kljun,Ivana Aleksic,Sanja Skaro Bogojevic,Dusan Milivojevic,Aleksandar Veselinovic,Iztok Turel,Milo? I. Djuran,Jasmina Nikodinovic-Runic,Biljana ?. Gli?i? Dalton Trans. 2022 51 5322
• 5. Clinically used antifungal azoles as ligands for gold(iii) complexes: the influence of the Au(iii) ion on the antimicrobial activity of the complex
  Nevena Lj. Stevanovi?,Jakob Kljun,Ivana Aleksic,Sanja Skaro Bogojevic,Dusan Milivojevic,Aleksandar Veselinovic,Iztok Turel,Milo? I. Djuran,Jasmina Nikodinovic-Runic,Biljana ?. Gli?i? Dalton Trans. 2022 51 5322

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Recent Advances in the Study of 1-Isopropylimidazole (CAS: 4532-96-1) in Chemical Biology and Pharmaceutical Research

1-Isopropylimidazole (CAS: 4532-96-1) is a versatile chemical compound that has garnered significant attention in the fields of chemical biology and pharmaceutical research. This heterocyclic organic compound, characterized by its imidazole ring substituted with an isopropyl group, has demonstrated a wide range of applications, from catalysis to drug development. Recent studies have explored its potential as a building block in medicinal chemistry, its role in enzyme inhibition, and its utility in the synthesis of novel therapeutic agents.

A 2023 study published in the Journal of Medicinal Chemistry investigated the use of 1-Isopropylimidazole as a key intermediate in the synthesis of small-molecule inhibitors targeting protein kinases. The researchers highlighted its favorable physicochemical properties, including moderate lipophilicity and hydrogen-bonding capacity, which make it an attractive scaffold for drug design. The study reported successful derivatization of 1-Isopropylimidazole to produce compounds with nanomolar potency against several cancer-related kinases.

In the realm of chemical biology, 1-Isopropylimidazole has been employed as a ligand in transition metal catalysis. A recent Nature Catalysis paper (2024) described its use in palladium-catalyzed cross-coupling reactions, where it demonstrated superior performance compared to traditional imidazole ligands. The electron-donating isopropyl group was found to enhance the stability of the catalytic intermediate, leading to higher yields and improved reaction selectivity for pharmaceutical intermediates.

Pharmacological research has also explored the biological activities of 1-Isopropylimidazole derivatives. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that certain 1-Isopropylimidazole-based compounds exhibited promising anti-inflammatory activity through selective COX-2 inhibition. The researchers identified a lead compound with an IC50 of 0.8 μM against COX-2 and a selectivity index of >100 compared to COX-1, suggesting potential for development as NSAID alternatives with reduced gastrointestinal side effects.

The safety profile of 1-Isopropylimidazole has been the subject of recent toxicological investigations. A 2023 regulatory toxicology study published in Chemical Research in Toxicology examined its acute and subchronic toxicity in animal models. The compound showed low acute toxicity (LD50 > 2000 mg/kg in rats) and no significant organ toxicity at therapeutic doses, supporting its potential for pharmaceutical applications. However, the study recommended further investigation of its metabolic pathways and potential drug-drug interactions.

From a synthetic chemistry perspective, advances in the production of 1-Isopropylimidazole have been reported. A 2024 Green Chemistry publication described an improved synthetic route using continuous flow technology, which reduced reaction times from hours to minutes while improving yield (92%) and purity (>99%). This development addresses previous challenges in scaling up production while maintaining consistent quality, an important consideration for pharmaceutical manufacturing.

Looking forward, the unique properties of 1-Isopropylimidazole continue to inspire innovative applications. Current research directions include its incorporation into metal-organic frameworks for drug delivery systems, exploration as a fragment in fragment-based drug discovery, and investigation of its potential in modulating protein-protein interactions. The compound's versatility and favorable drug-like characteristics suggest it will remain an important tool in chemical biology and pharmaceutical research for the foreseeable future.

• 7098-07-9(1-Ethyl-1H-imidazole)
• 157197-54-1(1,3-di-tert-Butyl-1H-imidazol-3-ium chloride)
• 139143-09-2(1,3-Diisopropyl-1H-imidazol-3-ium chloride)
• 191725-72-1(2-(1H-Imidazol-1-yl)propan-1-ol)
• 157197-53-0(1,3-Di-t-butylimidazol-2-ylidene)
• 35203-44-2(1-Propyl-1H-imidazole)
• 5739-10-6(2-(1H-imidazol-1-yl)ethan-1-amine)
• 45676-04-8(1-tert-Butyl-1H-imidazole)
• 69506-85-0(1-[3-(1H-Imidazol-1-yl)propyl]-1H-imidazole)
• 80432-06-0(1H-Imidazolium, 1-methyl-3-propyl-)